Amneal to report Q3 2026 earnings on Nov 3 with a live webcast.

Amneal Pharmaceuticals announced it will release its third quarter 2026 financial results on November 3, 2026, before the market opens. The company will host a live audio webcast at 8:30 a.m. ET to discuss the results, accessible via its investor relations website. This update is significant as Amneal continues to expand its portfolio in generics, specialty, and biosimilar medicines, impacting its growth trajectory. Investors can register for the webcast or listen via phone, with a replay available after the call.

Amneal Pharmaceuticals shares are currently trading at USD 19.79 on Pluang, showing a modest gain of 0.71% in the last day. The stock's market cap stands at $6.84 billion as of Oct 08, 2026 19:12 WIB.